Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones
NCT ID: NCT01514032
Last Updated: 2012-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
230 participants
INTERVENTIONAL
2011-10-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Trial with surgical intervention
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Flexible urétéroscopy Versus Extracorporeal Shockwave Lithotripsy in Renal Calculi
NCT01604304
The Efficacy of Oral Dissolution Therapy (ODT), Extracorporeal Shock Wave Lithotripsy (ESWL), and Combined ESWL and ODT as Non-Invasive Modalities for Treating Small and Medium-Sized Radiolucent Renal Stones
NCT06814834
Extracorporeal Shockwave Lithotripsy, Electroconductive and Electrohydraulic Types
NCT06144372
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney
NCT00959153
Management of Medium Sized Renal Stones
NCT06720311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extracorporal shockwave lithotripsy
Extracorporal shockwave lithotripsy
Extracorporal shockwave lithotripsy
Retrograde intrarenal surgery
Retrograde intrarenal surgery
Retrograde intrarenal surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extracorporal shockwave lithotripsy
Extracorporal shockwave lithotripsy
Retrograde intrarenal surgery
Retrograde intrarenal surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed consent signed by patient after explanation of the both treatment-modalities
Exclusion Criteria
* breastfeeding mother
* disorders of blood clotting
* kidneystones \> 15mm
* aneurysms of the aorta or renal artery
* severe skeletal deformations which hamper one of the treatment modalities
* synchronous stones of the ipsilateral ureter
* stones which can not visualized which X-ray or sonography
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
01 Studienregister MasterAdmins
Role: STUDY_DIRECTOR
UniversitaetsSpital Zuerich
Michael Muentener, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Division of urology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Urology
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TOP-Stone
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.